Loss of MafA and MafB expression promotes islet inflammation.
Tania SinghJesper K ColbergLuis SarmientoPatricia ChavesLisbeth HansenSara BsharatLuis R CataldoMonika Dudenhöffer-PfeiferMalin FexDavid BryderDan HolmbergEwa SitnickaCorrado CilioRashmi B PrasadIsabella ArtnerPublished in: Scientific reports (2019)
Maf transcription factors are critical regulators of beta-cell function. We have previously shown that reduced MafA expression in human and mouse islets is associated with a pro-inflammatory gene signature. Here, we investigate if the loss of Maf transcription factors induced autoimmune processes in the pancreas. Transcriptomics analysis showed expression of pro-inflammatory as well as immune cell marker genes. However, clusters of CD4+ T and B220+ B cells were associated primarily with adult MafA-/-MafB+/-, but not MafA-/- islets. MafA expression was detected in the thymus, lymph nodes and bone marrow suggesting a novel role of MafA in regulating immune-cell function. Analysis of pancreatic lymph node cells showed activation of CD4+ T cells, but lack of CD8+ T cell activation which also coincided with an enrichment of naïve CD8+ T cells. Further analysis of T cell marker genes revealed a reduction of T cell receptor signaling gene expression in CD8, but not in CD4+ T cells, which was accompanied with a defect in early T cell receptor signaling in mutant CD8+ T cells. These results suggest that loss of MafA impairs both beta- and T cell function affecting the balance of peripheral immune responses against islet autoantigens, resulting in local inflammation in pancreatic islets.
Keyphrases
- lymph node
- poor prognosis
- transcription factor
- gene expression
- bone marrow
- immune response
- genome wide identification
- oxidative stress
- binding protein
- endothelial cells
- single cell
- long non coding rna
- multiple sclerosis
- neoadjuvant chemotherapy
- squamous cell carcinoma
- drug induced
- toll like receptor
- diabetic rats
- endoplasmic reticulum stress